You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

CLINICAL TRIALS PROFILE FOR DIFLUPREDNATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Difluprednate

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00405496 ↗	Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis	Completed	Sirion Therapeutics, Inc.	Phase 2	2000-03-01	The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of uveitis.
NCT00406341 ↗	Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation	Completed	Sirion Therapeutics, Inc.	Phase 3	2004-04-01	The purpose of this phase 3 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
NCT00406497 ↗	Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation	Completed	Sirion Therapeutics, Inc.	Phase 2	2003-04-01	The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
NCT00406887 ↗	Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis	Completed	Sirion Therapeutics, Inc.	Phase 3	2002-08-01	The purpose of this phase 3 confirmatory study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of treatment of uveitis.
NCT00407056 ↗	Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis	Completed	Sirion Therapeutics, Inc.	Phase 3	2002-08-01	The purpose of this phase 3 open-labeled study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of severe uveitis.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Difluprednate

Condition Name

Chart
Table

Condition Name for Difluprednate
Intervention	Trials
Inflammation	8
Cataract	3
Uveitis	3
Anterior Uveitis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Difluprednate
Intervention	Trials
Inflammation	11
Uveitis	8
Uveitis, Anterior	5
Cataract	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Difluprednate

Trials by Country

Map
Table

Trials by Country for Difluprednate
Location	Trials
United States	15
Mexico	3
India	2
Egypt	1
Argentina	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Difluprednate
Location	Trials
Texas	3
Florida	3
California	2
Missouri	2
South Carolina	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Difluprednate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Difluprednate
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	12
Phase 2	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Difluprednate
Clinical Trial Phase	Trials
Completed	17
Recruiting	2
Not yet recruiting	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Difluprednate

Sponsor Name

Chart
Table

Sponsor Name for Difluprednate
Sponsor	Trials
Sirion Therapeutics, Inc.	12
Alcon Research	4
Cathleen McCabe MD	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Difluprednate
Sponsor	Trials
Industry	19
Other	13
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.